Breast cancer is divided into three subtypes for alignment with therapy options: estrogen receptor-positive, HER2-positive, and triple-negative (for a lack of estrogen receptor and progesterone receptor, and a lack of HER2 gene amplification) breast cancer. Here, ERBB2 is linked to breast cancer.